.Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01C_AgentsAgainstLeishmaniasisAndTrypanosomiasis.P01CB01_MeglumineAntimonate.MeglumineAntimonate .Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01C_AgentsAgainstLeishmaniasisAndTrypanosomiasis.P01CB01_MeglumineAntimonate.MeglumineAntimonate| name: | MeglumineAntimonate | |
| ATC code: | P01CB01 | route: | intramuscular |
| compartments: | 2 | |
| dosage: | 20 | mg |
| volume of distribution: | 0.21 | L |
| clearance: | 0.05 | L/kg/h |
| other parameters in model implementation | ||
Meglumine antimonate is a pentavalent antimonial compound historically used in the treatment of leishmaniasis, a parasitic disease. It is administered parenterally and is no longer the first-line therapy in many settings due to toxicity and the development of newer drugs.
Pharmacokinetic parameters reported in adults with cutaneous leishmaniasis after intramuscular administration.